[
    {
        "releaseTime": "Feb-25-23 06:25AM",
        "title": "3 Stocks to Buy Right Now That Are Cash Cows",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/da32cc0e-83b7-3938-85a6-2a95fc56478e/3-stocks-to-buy-right-now.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-24-23 03:00PM",
        "title": "The painfully high price of Humira is patently wrong",
        "publisher": " Financial Times",
        "webUrl": "https://finance.yahoo.com/m/7c6e4c07-f364-3662-b463-04b26bf84669/the-painfully-high-price-of.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-23-23 06:30AM",
        "title": "7 Dividend Yield Monsters Poised to Soar",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-dividend-yield-monsters-poised-113024088.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-23-23 05:01AM",
        "title": "AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-capsida-biotherapeutics-expand-strategic-100100363.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-22-23 02:12PM",
        "title": "10 Best March Dividend Stocks To Buy",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/10-best-march-dividend-stocks-191234835.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-22-23 09:39AM",
        "title": "Want to Get to $1 Million by Retirement? Here's How Much You Should Invest Today.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/af81b849-b557-3eb8-8bc6-31b5bbf3ff8a/want-to-get-to-%241-million-by.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-22-23 07:30AM",
        "title": "Want More Reliable Dividend Income? Buy This Dividend King.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/3d5a3a8a-b4d1-3c66-b966-07a9086a33ad/want-more-reliable-dividend.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-21-23 06:48PM",
        "title": "Biosimilars Were Supposed to Tame Costs for Drugs Like Humira. It Isnt Working.",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/72eaf908-5328-36be-997a-482f57631ff2/%E2%80%98biosimilars%E2%80%99-were-supposed.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-21-23 03:01PM",
        "title": "AbbVie accused of overcharging Dutch for flagship drug Humira",
        "publisher": " Financial Times",
        "webUrl": "https://finance.yahoo.com/m/b8966584-1182-39a4-a63d-bb4783878bc4/abbvie-accused-of.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-21-23 10:13AM",
        "title": "The Argus High-Yield Model Portfolio",
        "publisher": " Argus Research",
        "webUrl": "https://finance.yahoo.com/m/823b315e-e5a4-3b1e-a173-daae0e219a49/the-argus-high-yield-model.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-20-23 07:25AM",
        "title": "3 Top Dividend Kings to Buy for the Long Haul",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/8a6f40ef-d597-32c1-91c3-6cd014e7b921/3-top-dividend-kings-to-buy.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-20-23 05:12AM",
        "title": "AbbVie Full Year 2022 Earnings: EPS Misses Expectations",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-full-2022-earnings-eps-101242355.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-19-23 07:30PM",
        "title": "Why sales of Botox and other cosmetic injections may be resilient in a recession",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/3ba43494-eca7-3d0a-a4da-b3954d3a1c40/why-sales-of-botox-and-other.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-19-23 02:34PM",
        "title": "Why Botox and other cosmetic injections may be resilient against economic uncertainty",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/3ba43494-eca7-3d0a-a4da-b3954d3a1c40/why-botox-and-other-cosmetic.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-19-23 02:22PM",
        "title": "A Botox index: Why sales of cosmetic injections arent disappearing amid economic uncertainty",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/3ba43494-eca7-3d0a-a4da-b3954d3a1c40/a-botox-index%3A-why-sales-of.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-19-23 10:11AM",
        "title": "15 Best Safe Dividend Stocks For 2023",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-best-safe-dividend-stocks-151151211.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-18-23 09:00AM",
        "title": "3 Dividend Stocks That Should Pay You the Rest of Your Life",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0258158b-02b0-35b7-a7b6-832e8fa1ab23/3-dividend-stocks-that-should.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-17-23 11:11AM",
        "title": "Ironwood (IRWD) Q4 Earnings Miss, Linzess Volume Increases",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/ironwood-irwd-q4-earnings-miss-161104746.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-17-23 08:30AM",
        "title": "2 Exceptional Growth Stocks to Buy Before the Next Bull Market",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/850a80a8-44d2-3004-9a61-48611c22f4c7/2-exceptional-growth-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-17-23 06:01AM",
        "title": "These 4 Measures Indicate That AbbVie (NYSE:ABBV) Is Using Debt Reasonably Well",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/4-measures-indicate-abbvie-nyse-110116364.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-17-23 05:30AM",
        "title": "3 Exceptional Dividend Stocks to Buy Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/e83dd56e-1249-34d4-941c-3978a3b93574/3-exceptional-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-16-23 12:41PM",
        "title": "AbbVie Declares Quarterly Dividend",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-174100092.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-16-23 10:07AM",
        "title": "These 2 Growth Stocks Are Easily Defying the Bear Market",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/caf0938c-0dc1-3613-abb6-a18b903b52ee/these-2-growth-stocks-are.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-16-23 09:10AM",
        "title": "Is This the Start of a Nightmare for AbbVie Stock?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/f5c09198-0c99-3540-9a62-a4b3161caf3c/is-this-the-start-of-a.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-15-23 07:11PM",
        "title": "Early Retirement Portfolio: 15 Stocks to Live Off Dividends Revisited",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/early-retirement-portfolio-15-stocks-001129511.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-14-23 11:14AM",
        "title": "2 High-Yielding Dividend Stocks Trading Near 52-Week Lows",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6f419d50-30f8-36df-afde-e65e6fbdb898/2-high-yielding-dividend.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-14-23 09:07AM",
        "title": "3 of the BEST Dividend Growth Stocks",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/5296f76e-0b72-3f52-8ed4-4c5afd36794f/3-of-the-best-dividend-growth.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-14-23 09:00AM",
        "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-140002976.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-14-23 08:26AM",
        "title": "Better Buy: Johnson & Johnson or AbbVie?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/52c710e2-68d0-3dfc-8026-ad0dc30e19a1/better-buy%3A-johnson-%26-johnson.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-14-23 07:20AM",
        "title": "Ironwood (IRWD) Gets FDA Priority Tag for Linzess sNDA",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/ironwood-irwd-gets-fda-priority-122012850.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-13-23 04:03PM",
        "title": "15 Dividend Growth Stocks with the Highest Growth Rates",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-dividend-growth-stocks-highest-210333283.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-13-23 08:00AM",
        "title": "A Closer Look At AbbVie Inc.'s (NYSE:ABBV) Impressive ROE",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/closer-look-abbvie-inc-nyse-130021121.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-11-23 06:00AM",
        "title": "Here's Exactly How AbbVie Stock Can Beat the Market In 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/8a0d6af2-9019-3bb7-a721-09dd43af3d6a/here%27s-exactly-how-abbvie.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-10-23 04:05PM",
        "title": "AbbVie's Humira: The Downfall Won't Be As 'Draconian' As Initially Expected",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/ecc3597b-671a-3c9b-a7b5-42c207b3a0c3/abbvie%27s-humira%3A-the-downfall.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-10-23 09:05AM",
        "title": "Pharma Stock Roundup: AZN, ABBV Mixed Q4 Results, BAYRY's New CEO",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pharma-stock-roundup-azn-abbv-140502233.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-10-23 08:55AM",
        "title": "Compared to Estimates, AbbVie (ABBV) Q4 Earnings: A Look at Key Metrics",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/compared-estimates-abbvie-abbv-q4-135501139.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 06:00PM",
        "title": "AbbVie (ABBV) Q4 2022 Earnings Call Transcript",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/75bf97f1-d6fd-3a56-b6b6-3812453d6a2a/abbvie-%28abbv%29-q4-2022.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 04:04PM",
        "title": "AbbVie Rises As Lagging Profit Outlook Better Than Feared In Humira Battle Year",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/08278743-7923-3379-9b49-a1580f72ef07/abbvie-rises-as-lagging.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 01:42PM",
        "title": "AbbVie cites 'solid foundation' to weather Humira competition",
        "publisher": " American City Business Journals",
        "webUrl": "https://finance.yahoo.com/m/72e03418-9b52-3f13-b285-13f0de0662dd/abbvie-cites-%27solid.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 12:58PM",
        "title": "The End of AbbVies $200 Billion Monopoly Wont Sink the Stock",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/f1a5dd5c-31e1-3097-9d26-e1ae214d7841/the-end-of-abbvie%E2%80%99s-%24200.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 12:34PM",
        "title": "Analyst Report: AbbVie Inc.",
        "publisher": " Morningstar Research",
        "webUrl": "https://finance.yahoo.com/m/a5535bfe-f18a-3998-bbab-4107b9bfbea6/analyst-report%3A-abbvie-inc..html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 11:37AM",
        "title": "AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-beats-q4-earnings-163704638.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 11:02AM",
        "title": "Credit Suisse sees 96% plunge in equity trading revenue, plus other stocks on the move",
        "publisher": " Yahoo Finance Video",
        "webUrl": "https://finance.yahoo.com/video/credit-suisse-sees-96-plunge-160214195.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 10:21AM",
        "title": "Dow Jones Rallies 250 Points After Jobless Claims; Disney Surges On Earnings",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/334e5068-48b8-3082-acf0-a51cd50df2f2/dow-jones-rallies-250-points.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 10:15AM",
        "title": "AbbVie Posts an Earnings Beat but Forecast Misses as Competition Intensifies",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/9167e22c-ca88-3d67-83a8-744f54f76a2d/abbvie-posts-an-earnings-beat.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 10:10AM",
        "title": "AbbVie Beats On Q4 Earnings, Skyrizi Sales Grows 76%, Annual Guidance Lags Consensus",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/abbvie-beats-q4-earnings-skyrizi-151047038.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 09:32AM",
        "title": "Dow Jones Rises 225 Points After Jobless Claims; Disney Surges On Earnings",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/334e5068-48b8-3082-acf0-a51cd50df2f2/dow-jones-rises-225-points.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 09:10AM",
        "title": "Do Humira Biosimilars Threaten AbbVie's Dividend?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6a022492-6f3b-3310-9822-99b102cf92e1/do-humira-biosimilars.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 09:05AM",
        "title": "AbbVie (ABBV) Q4 Earnings Beat Estimates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-q4-earnings-beat-140502865.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 08:59AM",
        "title": "AbbVie Profit Outlook Widely Misses As The U.S. Humira Battle Kicks Off",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/08278743-7923-3379-9b49-a1580f72ef07/abbvie-profit-outlook-widely.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 08:58AM",
        "title": "Dow Jones Futures Rise 225 Points After Jobless Claims; Disney Surges On Earnings",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/334e5068-48b8-3082-acf0-a51cd50df2f2/dow-jones-futures-rise-225.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 08:35AM",
        "title": "Dow Jones Futures Rise After Jobless Claims; Disney Surges On Earnings",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/334e5068-48b8-3082-acf0-a51cd50df2f2/dow-jones-futures-rise-after.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 08:21AM",
        "title": "Dow Jones Futures Rise Ahead Of Jobless Claims; Disney Surges On Earnings",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/334e5068-48b8-3082-acf0-a51cd50df2f2/dow-jones-futures-rise-ahead.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 08:21AM",
        "title": "UPDATE 3-AbbVie sees 37% drop in Humira sales this year as biosimilars hit U.S. market",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-abbvies-2023-profit-forecast-132124083.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 08:04AM",
        "title": "AbbVies stock gains on Q4 results",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/ab7debd6-447e-38de-92e8-b8eb89a2c068/abbvie%E2%80%99s-stock-gains-on-q4.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 08:00AM",
        "title": "Is AbbVie Inc. (NYSE:ABBV) Trading At A 41% Discount?",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-nyse-abbv-trading-130022873.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 07:50AM",
        "title": "AbbVie's 2023 profit forecast misses as Humira faces heat from rivals",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvies-2023-profit-forecast-misses-125004885.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 07:45AM",
        "title": "AbbVie's 2023 profit forecast misses as Humira faces heat from rivals",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvies-2023-profit-forecast-misses-124537511.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 07:44AM",
        "title": "AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-reports-full-fourth-quarter-124400630.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-09-23 05:30AM",
        "title": "Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/91fa6a3a-0c12-3a46-82a9-db3419bf7082/pfizer%2C-novartis%2C-merck.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-07-23 12:17PM",
        "title": "Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvies-abbv-drugs-continue-drive-171705587.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-07-23 10:16AM",
        "title": "Strong Start, but Challenges Persist",
        "publisher": " Argus Research",
        "webUrl": "https://finance.yahoo.com/m/e68dbe5c-cc4a-3af6-8be6-59e1408d7b3a/strong-start%2C-but-challenges.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-07-23 05:41AM",
        "title": "3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/7316be97-f83a-3330-a1b1-1047b13773ca/3-high-yield-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-06-23 11:01AM",
        "title": "AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-report-q4-earnings-160104987.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-06-23 06:35AM",
        "title": "Abbvie plans to lift $2 billion cap on deals - WSJ",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvie-plans-lift-2-billion-113540113.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-06-23 05:30AM",
        "title": "AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/5bcfc1d3-b258-3a37-bc76-b688b4e2b9c0/abbvie-aims-for-new-drugs-to.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-05-23 08:46AM",
        "title": "12 Safe Stocks to Buy For Long-Term",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-safe-stocks-buy-long-134607791.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-05-23 07:00AM",
        "title": "AbbVie's (NYSE:ABBV) investors will be pleased with their favorable 80% return over the last three years",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvies-nyse-abbv-investors-pleased-120035536.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-04-23 08:30AM",
        "title": "2 Stocks Down More Than 6% to Buy Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/2e0d39a8-fbe3-373f-a0a8-d37e994f6b1b/2-stocks-down-more-than-6%25-to.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-04-23 07:45AM",
        "title": "3 Unstoppable Dividend Stocks to Buy in February",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/711633f8-6168-3fe6-8893-d95841fe4830/3-unstoppable-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 05:31PM",
        "title": "AbbVie Q4 Preview: What's in Store?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-q4-preview-whats-store-223110835.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 02:15PM",
        "title": "How Revance Therapeutics, The IBD 50's No. 1 Stock, Is Taking On 'Prestige' Medical Aesthetics",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/06b43a0a-b7c8-33b3-a988-f8c7065e7b23/how-revance-therapeutics%2C-the.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 01:19PM",
        "title": "10 Hot Healthcare Stocks To Buy Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/10-hot-healthcare-stocks-buy-181956435.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 10:07AM",
        "title": "If You Want Tons of Passive Income in the Future , Buy These 2 Stocks",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6bf0dc3d-ee3d-3b96-9133-fafd627a2771/if-you-want-tons-of-passive.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 09:00AM",
        "title": "Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/investors-heavily-search-abbvie-inc-140002295.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 09:00AM",
        "title": "2 Steady Stocks to Buy in a Recession",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/e3f627f9-3e5b-3d8d-8550-281554dbee0e/2-steady-stocks-to-buy-in-a.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 07:00AM",
        "title": "Top Fund Manager Found A Way To Make Money While Others Lose",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/c8b09758-c5a7-3c87-a4f9-b195a5e1b290/top-fund-manager-found-a-way.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 01:15AM",
        "title": "15 Cheapest Dividend Aristocrats Right Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-cheapest-dividend-aristocrats-now-061521556.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-03-23 12:58AM",
        "title": "Is AbbVie (ABBV) an Attractive Investment Option?",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-attractive-investment-option-055817493.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 12:52PM",
        "title": "Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/32ef9696-a4fb-3587-82e0-9eefba6d9a75/here%27s-what%27s-next-for.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 10:01AM",
        "title": "AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-earnings-expected-grow-150103650.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 09:53AM",
        "title": "2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/b6ed3095-ddca-3301-96c4-0fca342ca4b4/2-surefire-stocks-to-buy-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 09:00AM",
        "title": "3 Ultra-Profitable Businesses to Invest in for the Long Haul",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/4fedfdcc-651e-39e7-aac0-de0a60b64e81/3-ultra-profitable-businesses.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-02-23 07:55AM",
        "title": "Merck (MRK) Beats Q4 Earnings and Revenue Estimates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/merck-mrk-beats-q4-earnings-125512556.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 01:32PM",
        "title": "FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/focus-abbvies-humira-gets-u-183218523.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 12:36PM",
        "title": "Americas top-selling drug Humira loses monopoly status",
        "publisher": " Yahoo Finance Video",
        "webUrl": "https://finance.yahoo.com/video/america-top-selling-drug-loses-173623041.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 06:00AM",
        "title": "AbbVie Inc. (NYSE:ABBV) is a favorite amongst institutional investors who own 70%",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-nyse-abbv-favorite-110031131.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Feb-01-23 05:55AM",
        "title": "3 Juicy Dividend Stocks in Warren Buffett's Secret Portfolio to Buy in February",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/07104819-f2d2-3d6b-90d4-d1697e4ac378/3-juicy-dividend-stocks-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 04:04PM",
        "title": "AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/0813e7fa-501a-3817-98a4-73e590a163c8/abbvie%27s-two-decade-humira.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 01:07PM",
        "title": "First Humira Biosimilar Price Highlights Cost-Saving Challenges",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/17bde80c-13ac-3415-afee-a6cbe02f083a/first-humira-biosimilar-price.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 10:25AM",
        "title": "UPDATE 1-Amgen launches biosimilar version of AbbVie's Humira",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-amgen-launches-biosimilar-version-152539306.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 09:25AM",
        "title": "15 Largest Ophthalmology Companies in the World",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-largest-ophthalmology-companies-world-142505121.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 08:15AM",
        "title": "Pfizer (PFE) Q4 Earnings and Revenues Beat Estimates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-pfe-q4-earnings-revenues-131501821.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 07:36AM",
        "title": "FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/focus-abbvies-humira-gets-u-123635489.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:18AM",
        "title": "AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvies-humira-gets-u-rival-111842850.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:01AM",
        "title": "FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/focus-abbvies-humira-gets-u-110100507.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:00AM",
        "title": "Blockbuster AbbVie drug Humira to face competition in US for first time",
        "publisher": " Financial Times",
        "webUrl": "https://finance.yahoo.com/m/4161a541-ce1f-3452-a3b4-0987edf7fbe2/blockbuster-abbvie-drug.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:00AM",
        "title": "Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S.",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/2266a199-b468-3306-9beb-c3998aa24cda/blockbuster-arthritis-drug.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-31-23 06:00AM",
        "title": "Amgen launches biosimilar version of AbbVie's Humira",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/amgen-launches-biosimilar-version-abbvies-110000693.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-30-23 05:57PM",
        "title": "'Go big or go home': How a Peninsula biotech looks to win in Humira biosimilar 'feeding frenzy'",
        "publisher": " American City Business Journals",
        "webUrl": "https://finance.yahoo.com/m/fc869b9e-6e47-3378-b4df-ba15c9205986/%27go-big-or-go-home%27%3A-how-a.html",
        "company": "ABBV"
    }
]